ArticleOncotarget2017

AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.

Abhishek A Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.